Cargando…
OMRT-7. Angiogenesis inhibitors strongly synergize with therapeutics targeting tumor metabolism
Angiogenesis inhibition has become a mainstay of oncology despite having fallen short of its early promise. As originally envisioned, angiogenesis inhibition would cut off the blood supply, deprive tumor cells of key nutrients, leading to their death. In practice, while there is evidence that tumors...
Autor principal: | Khadka, Sunada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255441/ http://dx.doi.org/10.1093/noajnl/vdab070.032 |
Ejemplares similares
-
OMRT-8. Precision targeting of cellular pathways with complementary diagnostics
por: Siddaway, Robert, et al.
Publicado: (2021) -
OMRT-11. The effect of microenvironment on glioblastoma stem cells therapeutic resistance
por: Turnsek, Tamara Lah, et al.
Publicado: (2021) -
OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma
por: Rendo, Veronica, et al.
Publicado: (2021) -
OMRT-1. Cannabidiol converts NFKB into a tumor-suppressor in glioblastoma with defined antioxidative properties
por: Volmar, Marie, et al.
Publicado: (2021) -
OMRT-5. Therapy-induced reprogramming drives glioma vascular transdifferentiation and recurrence
por: Muthukrishnan, Sree Deepthi, et al.
Publicado: (2021)